Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Rhythm Pharmaceuticals (RYTM) Other Gross PP&E Adjustments (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 240.12% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 240.12% increase, with the full-year FY2025 number at $3.3 million, up 240.12% from a year prior.
  • Other Gross PP&E Adjustments was $3.3 million for Q4 2025 at Rhythm Pharmaceuticals, up from -$9.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.3 million in Q4 2025 to a low of -$9.4 million in Q3 2025.
  • A 5-year average of -$2.8 million and a median of -$2.2 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 336.75% in 2023, then crashed 748.28% in 2024.
  • Rhythm Pharmaceuticals' Other Gross PP&E Adjustments stood at $1.4 million in 2021, then tumbled by 123.95% to -$332000.0 in 2022, then soared by 336.75% to $786000.0 in 2023, then tumbled by 400.0% to -$2.4 million in 2024, then surged by 240.12% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Other Gross PP&E Adjustments are $3.3 million (Q4 2025), -$9.4 million (Q3 2025), and -$3.7 million (Q2 2025).